Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
Torosoff, Mikhail T; Sidhu, Mandeep S; Desai, Karan P; Fein, Steven A; Boden, William E.
J Comp Eff Res
; 4(5): 505-14, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26387530
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.
The Current State of Left Main Percutaneous Coronary Intervention.
Extended dual antiplatelet therapy after acute myocardial infarction. Current evidence and future perspectives.
Characteristics and outcomes of patients with percutaneous coronary intervention for unprotected left main coronary artery disease: a Hong Kong experience.
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Percutaneous Coronary Intervention: 2015 in Review.
Appropriateness of percutaneous coronary intervention: a review.
Ischemia-guided percutaneous coronary intervention for patients with stable coronary artery disease.
Innovative approaches to percutaneous bifurcation interventions using drug-eluting balloons.
The coronary heart team.